These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinians. Cao A; Pintus L; Lecca U; Olla G; Cossu P; Rosatelli C; Galanello R Clin Genet; 1984 Jul; 26(1):12-22. PubMed ID: 6205797 [TBL] [Abstract][Full Text] [Related]
5. Results from the north cyprus thalassemia prevention program. Bozkurt G Hemoglobin; 2007; 31(2):257-64. PubMed ID: 17486509 [TBL] [Abstract][Full Text] [Related]
6. Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain. Modell B; Petrou M; Ward RH; Fairweather DV; Rodeck C; Varnavides LA; White JM Lancet; 1984 Dec; 2(8416):1383-6. PubMed ID: 6150377 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants. Theodoridou S; Prapas N; Balassopoulou A; Boutou E; Vyzantiadis TA; Adamidou D; Delaki EE; Yfanti E; Economou M; Teli Α; Karakasidou O; Skatharoudi E; Theodoridis T; Voskaridou E Hemoglobin; 2018 Jul; 42(4):257-263. PubMed ID: 30501529 [TBL] [Abstract][Full Text] [Related]
8. Thalassaemia as a model of recessive genetic disease in the community. Mouzouras M; Camba L; Ioannou P; Modell B; Constantinides P; Gale R Lancet; 1980 Sep; 2(8194):574-8. PubMed ID: 6106748 [TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analysis of a national thalassaemia prevention programme in Israel. Ginsberg G; Tulchinsky T; Filon D; Goldfarb A; Abramov L; Rachmilevitz EA J Med Screen; 1998; 5(3):120-6. PubMed ID: 9795870 [TBL] [Abstract][Full Text] [Related]
10. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Cao A; Furbetta M; Galanello R; Melis MA; Angius A; Ximenes A; Rosatelli C; Ruggeri R; Addis M; Tuveri T; Falchi AM; Paglietti E; Scalas MT Am J Hum Genet; 1981 Jul; 33(4):592-605. PubMed ID: 7258188 [TBL] [Abstract][Full Text] [Related]
11. [The prevention of beta-thalassemia homozygosity]. Vullo C; Lucci M; Toffoli C Recenti Prog Med; 1992 Jan; 83(1):46-55. PubMed ID: 1561483 [TBL] [Abstract][Full Text] [Related]
12. Thalassaemia: a preventable disease? Pallister CJ Prof Nurse; 1992 Jul; 7(10):666-9. PubMed ID: 1626016 [No Abstract] [Full Text] [Related]
16. Population screening for carrier of recessively inherited disorders. Modell B; Mouzouras M; Camba L; Ward RH; Fairweather DV Lancet; 1980 Oct; 2(8198):806. PubMed ID: 6107488 [No Abstract] [Full Text] [Related]
17. Prevention of thalassaemia and haemoglobin S syndromes in Greece. Fessas P Acta Haematol; 1987; 78(2-3):168-72. PubMed ID: 3120466 [TBL] [Abstract][Full Text] [Related]
18. Prevention and control of thalassemia at Saraburi Regional Hospital. Chareonkul P; Kraisin J J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529 [TBL] [Abstract][Full Text] [Related]
19. Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinia. Cao A; Furbetta M; Galanello R; Melis MA; Angius A; Rosatelli C; Ruggeri R; Addis M; Tuveri T; Falchi AM; Maccioni L; Paglietti E; Scalas MT Birth Defects Orig Artic Ser; 1982; 18(7):303-11. PubMed ID: 7159738 [No Abstract] [Full Text] [Related]
20. The prevention of thalassemia in Sardinia. Cao A; Rosatelli C; Galanello R; Monni G; Olla G; Cossu P; Ristaldi MS Clin Genet; 1989 Nov; 36(5):277-85. PubMed ID: 2598483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]